Anders Buur

Title: Innovator Anders Buur: Pioneering Crystalline Pharmaceutical Compounds

Introduction: Anders Buur, an accomplished inventor based in Allerød, Denmark, has made significant contributions to the field of pharmaceuticals with three patented innovations. His work primarily focuses on the crystalline forms of complex pharmaceutical compounds.

Latest Patents: Buur's latest inventions revolve around crystalline forms of a specific pharmaceutical compound, identified as '[9S-(9α,10β,12α)]-5,16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2′,1′-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester'. He elaborates on both the methods of preparation and various applications for these crystalline forms, showcasing the potential benefits for pharmaceutical advancements.

Career Highlights: Throughout his career, Buur has worked with prominent companies, including Cephalon, Inc. and Lifecycle Pharma A/S. His professional journey reflects a commitment to innovation, particularly in the development of pharmaceutical compounds that can enhance therapeutic efficacy and patient safety.

Collaborations: Anders Buur has collaborated with notable peers in the industry, including Michael Harold Rock and Heidi Lopez De Diego. These collaborations have likely enriched his approach to innovation and expanded the impact of his patented inventions within the pharmaceutical sector.

Conclusion: With a focus on novel crystalline forms of pharmaceutical compounds, Anders Buur continues to be a driving force in the field of drug development. His patents not only contribute to the existing body of knowledge but also pave the way for future advancements in pharmaceutical science.